<DOC>
	<DOCNO>NCT02030977</DOCNO>
	<brief_summary>To study effect Resveratrol supplement lipid profile , liver enzymes , inflammatory factor hepatic fibrosis patient Nonalcoholic Fatty Liver ( NAfLD ) , 50 patient refer Gastrointestinal ( GI ) clinic steatosis grade 1 randomly allocate receive 1 Resveratrol capsule placebos 12 week ; group advise adherence diet exercise program . At first end intervention , lipid profile , liver enzymes , inflammatory cytokine , liver fibrosis assess compare group .</brief_summary>
	<brief_title>The Effects Resveratrol Supplement Biochemical Factors Hepatic Fibrosis Patients With Nonalcoholic Steatohepatitis</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Age 18 older ; Evidence nonalcoholic steatohepatitis steatosis grade high equal 1 ultrasonography ; No history Alcohol consumption consume less 10 gram alcohol per day woman less 20 gram per day men ; Absence liver disorder , malignancy , cardiovascular , respiratory , kidney disorder ; Absence pregnancy lactation ; Absence take medication past three month ; Absence weight loss recent three month ; Absence endocrine metabolism disorder . Weight loss 10 % baseline body weight intervention period . Pregnancy ; Disliking continue study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>